These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3002925)

  • 21. Antihypertensive action of a new angiotensin converting enzyme inhibitor, (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5-tetr ahy dro-1,5-benzothiazepine-5-acetic acid (CV-5975), in various hypertensive models.
    Inada Y; Tanabe M; Kawazoe K; Nishikawa K
    Jpn J Pharmacol; 1988 Jul; 47(3):311-22. PubMed ID: 2851677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive effects of nisoldipine and reference drugs in certain types of hypertensive rats.
    Tasaka K; Kamei C; Tagami H; Hokonohara T; Sugimoto Y
    Arzneimittelforschung; 1987 Mar; 37(3):316-21. PubMed ID: 3297074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive activity of a new ACE-inhibitor, SCH 33844, during repeated administration in spontaneously hypertensive rats.
    Monopoli A; Forlani A; Lazzaroni A; Milani S; Guzzon V
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):246-54. PubMed ID: 3036029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T; Becker FT; Sybertz EJ
    Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.
    Ryan MJ; Boucher DM; Cohen DM; Olszewski BJ; Singer RM; Smith RD; Kaplan HR
    Fed Proc; 1984 Apr; 43(5):1330-2. PubMed ID: 6323224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models.
    Inada Y; Tanabe M; Shibouta Y; Kawazoe K; Nishikawa K; Kikuchi S
    Jpn J Pharmacol; 1986 Sep; 42(1):1-8. PubMed ID: 3025485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive effect of total flavonoid fraction of Astragalus complanatus in hypertensive rats.
    Li JX; Xue B; Chai Q; Liu ZX; Zhao AP; Chen LB
    Chin J Physiol; 2005 Jun; 48(2):101-6. PubMed ID: 16201455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depressor effects of captopril in DOCA-salt hypertensive rats: role of vasopressin.
    Igarashi Y; Suzuki H; Itaya Y; Kondo K; Saruta T
    J Hypertens; 1985 Apr; 3(2):149-53. PubMed ID: 3894513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of DOCA-salt on angiotensin dependency and surgical reversal of hypertension in two-kidney, one clip renal hypertensive rats.
    Takata Y; Doyle AE
    J Hypertens; 1983 Jun; 1(1):57-63. PubMed ID: 6397514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
    Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K; Zhang X; Dunham EW; Zimmerman BG
    Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
    Racasan S; Hahnel B; van der Giezen DM; Blezer EL; Goldschmeding R; Braam B; Kriz W; Koomans HA; Joles JA
    Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enalapril maleate versus captopril. A comparison of the hormonal and antihypertensive effects.
    Ayers CR; Baker KM; Weaver BA; Lehman MR
    Drugs; 1985; 30 Suppl 1():70-3. PubMed ID: 2994989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].
    Kido H; Nishikawa M; Hayashi K; Kubo Y; Ohtaki Y; Fujino Y; Egi Y; Ebisu H; Inoue S; Yamanaga K; Uchida T; Nakamura N
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):279-89. PubMed ID: 9253775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of antihypertensive properties of captopril and enalapril after single and multiple oral administration in spontaneously hypertensive rats.
    Kosmala M; Oledzka K; Lewandowski K; Filczewski M; Miłobedzka J
    Pol J Pharmacol Pharm; 1992; 44(5):437-42. PubMed ID: 1297107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS; Ronsberg MA; Cervoni P
    Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of mineralocorticoid in the chronic antihypertensive effect of converting enzyme inhibitor.
    Maitra SR; Scicli AG; Miyazaki S; Carretero OA
    Hypertension; 1981; 3(2):205-10. PubMed ID: 7011962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
    Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.